Rofecoxib OverviewRofecoxib /rfkksb/ is a nonsteroidal anti-inflammatory drug (NSAID) that has now been withdrawn over safety concerns. It was marketed by Merck & Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhea. Rofecoxib was approved by the U.S. Food and Drug Administration (FDA) on May 20, 1999, and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx. Rofecoxib gained widespread acceptance among physicians treating patients with arthritis and other conditions causing chronic ...
Read more Rofecoxib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rofecoxib
Recent Rofecoxib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Suspension: 12.5mg/5ml, 25mg/5ml
- Tablet: 0, 0.0, 12.5mg, 25mg, 50mg